Chemed Corporation ( CHE) - Stock Earnings
CHE Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | 64.2 million USD | 624.9 million USD |
| 2025Q4 | 76.8 million USD | 639.3 million USD |
| 2026Q1 | 66.3 million USD | 657.5 million USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
CHE Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 272.5 million USD | 2.3 billion USD |
| 2024 | 302.0 million USD | 2.4 billion USD |
| 2025 | 265.2 million USD | 2.5 billion USD |
| 2026 Est. | — | — |
CHE
List: Contenders
Price: $426.86
Dividend Yield: 0.54%
Forward Dividend Yield: 0.58%
Payout Ratio: 10.15%
Dividend Per Share: 2.40 USD
Earnings Per Share: 18.31 USD
P/E Ratio: 23.35
Exchange: NYQ
Sector: Healthcare
Industry: Medical Care Facilities
Country: United States
Volume: 83400
Ebitda: 68.2 millionMarket Capitalization: 5.7 billion
Average Dividend Frequency: 4
Years Paying Dividends: 42
DGR3: 11.94%
DGR5: 9.59%
DGR10: 8.69%
DGR20: 15.98%